Britain’s drug regulator accepted the Alzheimer’s drug Kisunla on Wednesday, but The federal government gained’t be purchasing it soon after an impartial watchdog company said the cure isn’t definitely worth the cost to taxpayersWeather improve, civil conflict and growing resistance to insecticides and therapies are all contributing to an a